Eye on the Cure Podcast – Episode 35: Kenji Fujita, MD
November 18, 2022. Ben Shaberman talks with Kenji Fujita, MD.
Episode 35: Kenji Fujita, MD
November 18, 2022. Kenji Fujita, MD, chief medical officer at Atsena Therapeutics, talks to host Ben Shaberman about retinal disease gene therapies including positive results from his company's gene therapy clinical trial for people with Leber congenital amaurosis 1 (GUCY2D mutations) as well as Atsena's emerging gene therapies for X-linked retinoschisis and Usher syndrome type 1B.
To learn more about our podcasts and which platforms they are available to stream, visit the Foundation Podcasts page.